Expert Witness I R&D Executive I Life Science

Specialties & Experience of this Expert Witness

Additional Information

Dr. Abdel-Malik is a strategic innovation leader with extensive R&D and business development experience across the life sciences — encompassing pharmaceuticals, consumer health, cosmetics, dietary supplements, personal care, and medical devices. As Founder of Quaestio Global Partners (QGP), he has applied that expertise across leading global organizations — and today extends it as an Expert Witness in life sciences litigation. He is an Executive in Residence at Princeton University and a Grant Reviewer at Rutgers University. PHARMACEUTICALS AND CONSUMER PRODUCTS: AREAS OF EXPERTISE Dr. Abdel-Malik has developed comprehensive expertise across diverse therapeutic areas within pharmaceuticals and consumer products— including: Analytical Chemistry (NMR, MS, HPLC, GC, etc.), Carbohydrate Chemistry, Chemical Structure Characterization, Consumer Self-Care Products, Cosmetics & Dermo-Cosmetics, Dietary Supplements, Drug Delivery Systems (DDS), Formulation Technologies, Gastrointestinal (GI) Health (Gut Health, Microbiome, etc.), Hair Products, Innovation Assessment, Development & Commercialization, Intellectual Property (IP) Assessment, Medical Devices, Natural Products Chemistry, Nicotine Replacement Therapies, Oral Cavity Health (Mouthwash, Denture Cleansing, etc.), Organic Chemistry, Over-the-Counter (OTC) Medicines, Pain Management, Personal Care Products, Pharmaceutical Products, Polysaccharide and Biomaterials, Product Characterization & Structure Elucidation, Therapeutic Skin Care, Respiratory Health (Cough, Cold, Allergy, etc.), and Wound Healing. EXPERT WITNESS COMPETENCES: To date, Dr. Abdel-Malik has been engaged in 5+ matters spanning pharmaceuticals, consumer health, cosmetics, dietary supplements, personal care, and medical devices. Therapeutic focus areas include pain management, hair care, antiseptics, health and wellness, and rare disease indications. Services rendered include expert report preparation, deposition testimony, trial testimony, and litigation consulting. His opinions are grounded in extensive R&D, commercial and business development experience — not solely academic or theoretical expertise. He has identified overlooked evidence, closed technical gaps, and strengthened legal arguments through scientifically grounded findings supported by rigorous analysis. As an expert witness, he draws on firsthand experience leading the very R&D processes, product development decisions, commercial negotiations, and executive-level business judgment that frequently lie at the heart of life sciences disputes. He demonstrates composure and credibility under rigorous cross-examination and communicates complex scientific evidence clearly to legal teams, judges, and juries. His opinions are formed through methodologies grounded in advanced scientific training and extensive academic and industry experience. PROFESSIONAL EXPERIENCE: Founder & President of QGP, a boutique consulting firm specializing in R&D external innovation and strategic partnerships within the life sciences industry. QGP brings a deep understanding of R&D partnership creation from both the innovation seeker’s and the innovation provider’s perspectives — enabling collaborations that deliver measurable value. The total combined commercial value of QGP initiatives is estimated to exceed $4.8 billion. He has conducted extensive research and continues to advise R&D clients on R&D strategies, innovation assessment, product discovery, formulations, and commercialization. He previously pioneered Pfizer Consumer Healthcare’s Technology Search Process — a first-of-its-kind structured external innovation initiative within Consumer Healthcare industry. He led R&D efforts to establish the Complementary Medicines business unit and launched seven clinically studied products under the Quanterra brand. Prior experience includes Warner-Lambert and PepsiCo as well as other multinational organizations prior to relocating to the US.